RxDoctor Payments Data

Kristina Singley

Psychiatric/Mental Health · Athens, PANPI 1558029017

Payments from drug & device makers

$554in general payments, 2019–2025

Across 24 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$284
  • Axsome Therapeutics, Inc.$95
  • Otsuka America Pharmaceutical, Inc.$69
  • Neurocrine Biosciences, Inc.$26
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26
  • Novo Nordisk$20
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$554100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$554 in reported general payments places this provider in the 50th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$6,538
Medicare patients
53
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl25$35,281
TrintellixVortioxetine Hydrobromide24$11,814
Lurasidone Hcl11$5,660
Aripiprazole54$1,965
Olanzapine52$1,735
Vilazodone Hcl12$947
Bupropion XlBupropion Hcl53$898
Venlafaxine Hcl ErVenlafaxine Hcl62$803
Divalproex Sodium ErDivalproex Sodium32$800
Carbamazepine ErCarbamazepine11$775
Clonazepam115$774
Hydroxyzine Hcl31$769
Divalproex Sodium26$582
Trazodone Hcl58$545
Quetiapine Fumarate32$433

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$284$35,28125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Athens

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →